Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Bas C. Stunnenberg"'
Autor:
Jules M. Janssen Daalen, Marjan J. Meinders, Federica Giardina, Kit C. B. Roes, Bas C. Stunnenberg, Soania Mathur, Philip N. Ainslie, Dick H. J. Thijssen, Bastiaan R. Bloem
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Parkinson’s disease (PD) is a neurodegenerative disease, for which no disease-modifying therapies exist. Preclinical and clinical evidence suggest that hypoxia-based therapy might have short- and long-term benefits in PD. We pre
Externí odkaz:
https://doaj.org/article/e444660f0b144644abab9ac05a31d6ee
Autor:
Bas C. Stunnenberg, Jaap Deinum, Tom Nijenhuis, Frans Huysmans, Gert Jan van der Wilt, Baziel G.M. van Engelen, Frans van Agt
Publikováno v:
Healthcare, Vol 8, Iss 1, p 49 (2020)
N-of-1 trials can provide high-class evidence on drug treatment effectiveness at the individual patient level and have been given renewed interest over the past decade due to improvements of the initial single patient design. Despite these recent dev
Externí odkaz:
https://doaj.org/article/76100ed0b0a84b309f0a18972cd1e08a
Autor:
Maria Ponson-Wever, Ivo Peters, Bas C. Stunnenberg, Mieke M. van Haelst, Monique M. Gerrits, Eline A. Verberne, Charlotte A. Haaxma
Publikováno v:
Journal of Pediatric Neurology, 19(3):2000024, 189-192. Thieme Medical Publishers
Journal of Pediatric Neurology, 19, 03, pp. 189-192
Journal of Pediatric Neurology, 19(03), 189-192. IOS Press
Journal of Pediatric Neurology, 19(3):2000024, 189-192. Thieme Medical Publishers Inc.
Stunnenberg, B, Ponson-Wever, M, Verberne, E, Peters, I, Gerrits, M, Haaxma, C & Van Haelst, M 2021, ' Novel SCN9A Mutations in a Compound Heterozygous Girl with Congenital Insensitivity to Pain ', Journal of Pediatric Neurology, vol. 19, no. 3, 2000024, pp. 189-192 . https://doi.org/10.1055/s-0040-1714067
Journal of Pediatric Neurology, 19, 189-192
Journal of Pediatric Neurology, 19, 03, pp. 189-192
Journal of Pediatric Neurology, 19(03), 189-192. IOS Press
Journal of Pediatric Neurology, 19(3):2000024, 189-192. Thieme Medical Publishers Inc.
Stunnenberg, B, Ponson-Wever, M, Verberne, E, Peters, I, Gerrits, M, Haaxma, C & Van Haelst, M 2021, ' Novel SCN9A Mutations in a Compound Heterozygous Girl with Congenital Insensitivity to Pain ', Journal of Pediatric Neurology, vol. 19, no. 3, 2000024, pp. 189-192 . https://doi.org/10.1055/s-0040-1714067
Journal of Pediatric Neurology, 19, 189-192
Congenital Insensitivity to Pain (CIP) is a rare disorder that is characterized by the inability to perceive pain. It is caused by bi-allelic inactivating mutations in the SCN9A gene, which encodes the pore-forming α-subunit of the nerve voltage-gat
Autor:
Ellen 't Hoen, Stefan Kääb, Peter J. Schwartz, Wilbert J Bannenberg, Antoine Leenhardt, Josep Brugada, Pier D. Lambiase, Carla E. M. Hollak, Vincent Probst, Bernard Belhassen, Jacob Tfelt-Hansen, Ruben Casado-Arroyo, Bas C. Stunnenberg, Pieter G. Postema, Arthur A.M. Wilde, Baziel G.M. van Engelen, A. John Camm, Pedro Brugada, Silvia G. Priori, Christian Veltmann, Sami Viskin, Elena Arbelo, Elijah R. Behr
Publikováno v:
European Heart Journal, 41(5), 614-617. Oxford University Press
European Heart Journal, 41, 614-617
European Heart Journal, 41, 5, pp. 614-617
Postema, P G, Schwartz, P J, Arbelo, E, Bannenberg, W J, Behr, E R, Belhassen, B, Brugada, J, Brugada, P, John Camm, A, Casado-Arroyo, R, 't Hoen, E, Hollak, C E M, Kääb, S, Lambiase, P D, Leenhardt, A, Priori, S G, Probst, V, Stunnenberg, B C, Tfelt-Hansen, J, Van Engelen, B G M, Veltmann, C, Viskin, S & Wilde, A A M 2020, ' Continued misuse of orphan drug legislation : a life-threatening risk for mexiletine ', European Heart Journal, vol. 41, no. 5, pp. 614-617 . https://doi.org/10.1093/eurheartj/ehaa041
European Heart Journal, 41, 614-617
European Heart Journal, 41, 5, pp. 614-617
Postema, P G, Schwartz, P J, Arbelo, E, Bannenberg, W J, Behr, E R, Belhassen, B, Brugada, J, Brugada, P, John Camm, A, Casado-Arroyo, R, 't Hoen, E, Hollak, C E M, Kääb, S, Lambiase, P D, Leenhardt, A, Priori, S G, Probst, V, Stunnenberg, B C, Tfelt-Hansen, J, Van Engelen, B G M, Veltmann, C, Viskin, S & Wilde, A A M 2020, ' Continued misuse of orphan drug legislation : a life-threatening risk for mexiletine ', European Heart Journal, vol. 41, no. 5, pp. 614-617 . https://doi.org/10.1093/eurheartj/ehaa041
Contains fulltext : 218857.pdf (Publisher’s version ) (Closed access)
Autor:
Joost Berends, Hans Groenewoud, Bas C. Stunnenberg, Gert Jan van der Wilt, Robert C. Griggs, Gea Drost, Joost Raaphorst, Jane Nikles, Jeffrey Statland, Baziel G.M. van Engelen
Publikováno v:
Neurology, 98, e174-e185
Neurology, 98(2), E174-E185. Lippincott Williams and Wilkins
Neurology, 98, 2, pp. e174-e185
Neurology, 98(2), E174-E185. Lippincott Williams and Wilkins
Neurology, 98, 2, pp. e174-e185
Background and ObjectivesTo perform a systematic review of published N-of-1 trials (e.g., single patient crossover trials) in neurologic disorders, including an assessment of methodologic quality and reporting.MethodsWe searched PubMed, MEDLINE, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b514c443f75e7fe73862ccfcd94cdf
https://doi.org/10.1212/WNL.0000000000012998
https://doi.org/10.1212/WNL.0000000000012998
Autor:
Saco J. de Visser, Bas C. Stunnenberg, Vincent van der Wel, Sibren van den Berg, Carla E. M. Hollak, Pieter G. Postema, Martijn H. van der Ree, Lonneke Timmers
Publikováno v:
Value in health, 24(7), 925-929. Elsevier Limited
Value in Health, 24, 7, pp. 925-929
Value in Health, 24, 925-929
Value in Health, 24, 7, pp. 925-929
Value in Health, 24, 925-929
Objectives Mexiletine is a long-known drug used for the treatment of arrhythmias and repurposed in the 1980s for patients with nondystrophic myotonia (NDM). Recently, the price of mexiletine in Europe increased significantly after registration as an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81585791e81c45877867cde3930aeb5c
https://pure.amc.nl/en/publications/costbased-price-calculation-of-mexiletine-for-nondystrophic-myotonia(1108007c-ce8b-4e0e-adb9-162d3e0b33f6).html
https://pure.amc.nl/en/publications/costbased-price-calculation-of-mexiletine-for-nondystrophic-myotonia(1108007c-ce8b-4e0e-adb9-162d3e0b33f6).html
Autor:
Gert Jan van der Wilt, Jaap Deinum, Frans van Agt, Bas C. Stunnenberg, F.T.M. Huysmans, Tom Nijenhuis, Baziel G.M. van Engelen
Publikováno v:
Healthcare, Vol 8, Iss 1, p 49 (2020)
Healthcare
Healthcare, 8
Healthcare, 8, 1
Healthcare
Healthcare, 8
Healthcare, 8, 1
Contains fulltext : 218298.pdf (Publisher’s version ) (Open Access) N-of-1 trials can provide high-class evidence on drug treatment effectiveness at the individual patient level and have been given renewed interest over the past decade due to impro
Autor:
Jeffrey Statland, W. David Arnold, Giovanni Meola, Michael G. Hanna, Samantha LoRusso, Baziel G.M. van Engelen, Stephen C. Cannon, Emma Matthews, Valeria A. Sansone, Jaya Trivedi, Bertrand Fontaine, Bas C. Stunnenberg, Richard J. Barohn, Robert C. Griggs, Savine Vicart
Publikováno v:
Muscle & nerve. Supplement.
Muscle & nerve. Supplement., 2020, 62 (4), pp.430-444. ⟨10.1002/mus.26887⟩
Muscle Nerve
Muscle and Nerve, 62, 4, pp. 430-444
Muscle and Nerve, 62, 430-444
Muscle & nerve. Supplement., 2020, 62 (4), pp.430-444. ⟨10.1002/mus.26887⟩
Muscle Nerve
Muscle and Nerve, 62, 4, pp. 430-444
Muscle and Nerve, 62, 430-444
Contains fulltext : 229739.pdf (Publisher’s version ) (Closed access) The nondystrophic myotonias are rare muscle hyperexcitability disorders caused by gain-of-function mutations in the SCN4A gene or loss-of-function mutations in the CLCN1 gene. Cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84ec05a1420fbda18f320e371bf7d797
https://hal.sorbonne-universite.fr/hal-03461673
https://hal.sorbonne-universite.fr/hal-03461673
Autor:
Esther C Merkus, Baziel G.M. van Engelen, Bas van Vlijmen, Gert Jan van der Wilt, Bas C. Stunnenberg, Jeffrey Statland, Robert C. Griggs, Joost Raaphorst, Robyn Weijma, Christiaan G J Saris, Hans Groenewoud
Publikováno v:
Journal of Neurology, Neurosurgery and Psychiatry, 92(12):326347, 1352-1353. BMJ Publishing Group
Journal of Neurology, Neurosurgery, and Psychiatry, 92, 12, pp. 1352-1353
Journal of Neurology, Neurosurgery, and Psychiatry, 92, 1352-1353
Journal of Neurology, Neurosurgery, and Psychiatry, 92, 12, pp. 1352-1353
Journal of Neurology, Neurosurgery, and Psychiatry, 92, 1352-1353
Hyperkalemic periodic paralysis (HyperPP) is a rare neurological channelopathy caused by gain-of-function mutations in the skeletal muscle sodium channel gene ( SCN4A ) that disrupts sarcolemmal membrane excitability. Clinically, HyperPP is character
Autor:
Nicol C. Voermans, Nanna Witting, Yves Sznajer, Ingrid P.C. Krapels, Anneke J. van der Kooi, Benno Küsters, Amanda Krause, Bitten Schönewolf-Greulich, Karin Y. van Spaendonck-Zwarts, Corien C. Verschuuren-Bemelmans, Corrie E. Erasmus, Baziel G.M. van Engelen, Meyke Schouten, Suzanne C E H Sallevelt, Anneke J.A. Kievit, Rowdy Meijer, Christine E. M. de Die-Smulders, Marjolein Kriek, Daniela Q.C.M. Barge-Schaapveld, Dineke Westra, Christian Gillissen, Brian H.Y. Chung, Isabelle Maystadt, Christa de Geus, Sophelia H. S. Chan, Saskia Bulk, Bas C. Stunnenberg, Erica H. Gerkes, P. A. van der Zwaag, Magnhild Rasmussen, Maartje Pennings, Christiaan G J Saris, Erik-Jan Kamsteeg
Publikováno v:
Journal of neuromuscular diseases, 6(2), 241-258. IOS Press
Journal of Neuromuscular Diseases, 6, 241-258
Journal of Neuromuscular Diseases, 6(2), 241-258. IOS Press BV
Journal of Neuromuscular Diseases, Vol. 6, no.2, p. 241-258 (2019)
Journal of Neuromuscular Diseases, 6, 2, pp. 241-258
Journal of neuromuscular diseases, 6(2), 241-258. I O S Press
Journal of Neuromuscular Diseases, 6, 241-258
Journal of Neuromuscular Diseases, 6(2), 241-258. IOS Press BV
Journal of Neuromuscular Diseases, Vol. 6, no.2, p. 241-258 (2019)
Journal of Neuromuscular Diseases, 6, 2, pp. 241-258
Journal of neuromuscular diseases, 6(2), 241-258. I O S Press
Contains fulltext : 204157.pdf (Publisher’s version ) (Closed access) BACKGROUND: Neuromuscular disorders (NMDs) are clinically and genetically heterogeneous. Accurate molecular genetic diagnosis can improve clinical management, provides appropriat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba263fe5ec163190ab429e56dfc98ff
https://pure.amc.nl/en/publications/panelbased-exome-sequencing-for-neuromuscular-disorders-as-a-diagnostic-service(dc370bdc-e7ba-4d5a-920b-f1a625a5ece9).html
https://pure.amc.nl/en/publications/panelbased-exome-sequencing-for-neuromuscular-disorders-as-a-diagnostic-service(dc370bdc-e7ba-4d5a-920b-f1a625a5ece9).html